Crinetics Pharmaceuticals

Crinetics Pharmaceuticals Driving the next generation of endocrinology care. See our social community guidelines: https://crinetics.com/social-media-community-guidelines/

We are a global pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine disease and endocrine-related tumors. Driven by the belief that no one should be defined by their disease, we’re transforming endocrine care to significantly improve the lives of patients, caregivers, and loved ones. As the premier, endocrine-rooted pharmaceutical company, we’re shaping the future of treatment, empowering individuals to live beyond their condition, and thrive. Learn more at www.crinetics.com.

02/10/2026

Diagnosing acromegaly isn’t easy, its symptoms often hide in plain sight. But every story shared helps the world see more clearly. We’re proud to share the voices of people living with acromegaly, whose experiences continue to guide how we listen, learn, and innovate at Crinetics.

02/05/2026

Science. Collaboration. Wagging tails. 🐕🧪

Our office pups are part of what makes Crinetics feel like home. If you believe great science happens when people feel supported, and maybe get a few puppy cuddles along the way, we’re hiring. Learn more: https://bit.ly/3BmigiR

This World Cancer Day, we stand with the neuroendocrine tumor community.We’re committed to advancing understanding and a...
02/04/2026

This World Cancer Day, we stand with the neuroendocrine tumor community.
We’re committed to advancing understanding and addressing unmet needs in neuroendocrine tumors (NETs) and related conditions like carcinoid syndrome. Learn more here: https://bit.ly/3ZUBzZ2

Did you know? Acromegaly is caused by the chronic excess growth hormone, most often due to a benign tumor on the pituita...
01/29/2026

Did you know? Acromegaly is caused by the chronic excess growth hormone, most often due to a benign tumor on the pituitary gland. At Crinetics, we’re driven to better understand endocrine diseases like acromegaly and the people living with them. Learn more about how we’re advancing innovation for serious endocrine diseases: https://bit.ly/3XghDQx

The first patient has been dosed in the BALANCE-CAH Phase 2/3 trial evaluating our investigational, once-daily oral ACTH...
01/22/2026

The first patient has been dosed in the BALANCE-CAH Phase 2/3 trial evaluating our investigational, once-daily oral ACTH receptor antagonist in children and adolescents with classic CAH.

We’re grateful to the patients, families, and clinical teams advancing this important research.

Learn more here: https://bit.ly/49LB7kt

Energized from a week of meaningful conversations in San Francisco, connecting with the healthcare community, sharing ou...
01/15/2026

Energized from a week of meaningful conversations in San Francisco, connecting with the healthcare community, sharing our progress, and reinforcing our commitment to advancing the next generation of endocrinology care.

Thank you to everyone who spent time with the Crinetics team at JPM 2026.

Join us today at 9:45 a.m. PT as we present a company update highlighting advancements from our deep endocrinology pipel...
01/13/2026

Join us today at 9:45 a.m. PT as we present a company update highlighting advancements from our deep endocrinology pipeline, which was purposefully built to improve the lives of people with endocrine diseases.

Join the webcast: https://bit.ly/4pA3Ezm

01/12/2026

We’re excited to join fellow leaders in the biotech and healthcare community at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. Crinetics will highlight our significant achievements in 2025, share our outlook for 2026 and lay out our vision for 2030 during our corporate presentation on Tuesday, January 13 at 9:45 a.m. PT. Read more: https://bit.ly/49s6ikF

Celebrating where it all began! This week marks the 16th anniversary of Crinetics’ first lab, the spark that shaped our ...
01/06/2026

Celebrating where it all began! This week marks the 16th anniversary of Crinetics’ first lab, the spark that shaped our discovery engine and defined who we are. Built by scientists and endocrinologists, we’ve grown from a few benches and big ideas into a global company advancing innovative therapies for people with endocrine diseases. Swipe to see photos from our early days.

This year, we joined patient advocates, caregivers, and healthcare leaders around a shared goal: helping people with ser...
12/29/2025

This year, we joined patient advocates, caregivers, and healthcare leaders around a shared goal: helping people with serious endocrine diseases live better lives. Swipe to see some of the highlights from our year of partnership and purpose.

10/08/2025

Say hello to Guapo! 🐾 Living up to his name, Guapo is Torrie Plata’s handsome pup who loves bringing joy, cuddles, and a little extra sunshine to the office. We’re proud to be a workplace where dogs are part of our pack, wagging tails included: https://bit.ly/3BmigiR

Address

6055 Lusk Boulevard
San Diego, CA
92121

Alerts

Be the first to know and let us send you an email when Crinetics Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Crinetics Pharmaceuticals:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram